MedTrace Logo

Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms

NCT00535054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2010-02-09

No results posted yet for this study

Summary

The purpose of this study is to determine safety and patients' satisfaction when using Tears Again to treat Dry Eye Symptoms.

Conditions

  • Dry Eye Syndrome

Interventions

DRUG

Tears Again

Liposome Eye Spray

Sponsors & Collaborators

  • Trima, Israel Pharmaceutical Products

    lead INDUSTRY

Principal Investigators

  • David Zadok, MD · Department of Ophthalmology, Assaf Harofeh Medical Center,

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00535054 on ClinicalTrials.gov